Pegile İnterferon alfa/ribavirin tedaviyle gelişen sensorinöral tipte işitme kaybı

Oğuz Karabay; Mehmet Güven; Aziz Öğütlü; Süleyman Cesur; Deniz Gin; Nazan Tuna

doi:10.5505/abantmedj.2013.44153

Sensorineural type hearing loss with pegylated interferon alfa/ribavirin therapy

Year 2013, , 248 - 249, 01.09.2013

Oğuz Karabay Mehmet Güven Aziz Öğütlü Süleyman Cesur Deniz Gin Nazan Tuna

https://doi.org/10.5505/abantmedj.2013.44153

References

Howaizi M. Pegylated interferon-induced eyelid and eye- brow trichomegaly during chronic hepatitis C. J Gastroenterol Hepatol 2005; 20: 1945–1946.
Goksugur N, Karabay O. Eyelash and eyebrow trichomegaly induced by interferon-alfa 2a. Clin Exp Dermatol 2007; 32: 583–584.
Karabay O, Goksugur N, Ogutlu A. Tongue hyperpigmentation during interferon therapy. Journal of Dermatology. 2011; 38: 290-291.
Johnson K, Sargent LA, Galizio C, Ubogu EU. Interferon- alfa-2b/ribavirin-induced vestibulocochlear toxicity with dysautonomia in a chronic hepatitis C patient. Eur J Gastroenterol Hepatol 2008; 20: 1110-1114.
Atuğ O, Akın H, Yılmaz Y, Sarı M, Tozun N. Pegylated interferon/ribavirin-induced sudden sensorineural hearing loss in a patient with chronic hepatitis C. J Gastrointestin Liver Dis 2009; 18: 256.
Elloumi H, Houissa F, Hadj BN, Gargouri D, Romani M, Kharrat J, Ghorbel A. Sudden hearing loss associated with peginterferon and ribavirin combination theraphy during hepatitis C treatment. World J gastroenterol 2007; 28: 5411-5412.
Formann E, Stauber R, Denk DM, Jessner W, Zollner G, Munda-Steindl P, Gangl A, Ferenci P. Sudden hearing loss in patients with chronic hepatitis C treated with pegylated interferon/ribavirin. Am J Gastroenterol 2004; 99: 873–877.
Wong VK, Cheong-Lee C, Ford JA, Yoshida EM. Acute sensorineural hearing loss associated with peginterferon and ribavirin combination theraphy during hepatitis C treatment: Outcome after resumption of theraphy. World J Gastroenterol 2005; 11: 5392-5393.
Piekarska A, Jozefowicz-Korczynska M, Wojcik K, Berkan E. Sudden hearing loss in chronic hepatitis C patient suffering from Turner syndrome, treated with pegylated interferon and ribavirin. Int J Audiol 2007; 46(7): 345-350.
Hagr A, Jamjoom D, Sanai F.M, Al Hamoudi W, Abdo A.A, Al-Arfaj A. Effect of interferon treatment on hearing of patients with chronic Hepatitis C. Saudi J Gastroenterol 2011; 2: 114-118.
Akyol MU, Sarac S, Akyol G, Atac A, Poyraz A, Belgin E, Turan E. Investigation of the ototoxic effects of interferon alpha2A on the mouse cochlea Otolaryngol Head Neck Surg 2001 ;124(1): 107-110.

Pegile İnterferon alfa/ribavirin tedaviyle gelişen sensorinöral tipte işitme kaybı

Year 2013, , 248 - 249, 01.09.2013

Oğuz Karabay Mehmet Güven Aziz Öğütlü Süleyman Cesur Deniz Gin Nazan Tuna

https://doi.org/10.5505/abantmedj.2013.44153

References

Howaizi M. Pegylated interferon-induced eyelid and eye- brow trichomegaly during chronic hepatitis C. J Gastroenterol Hepatol 2005; 20: 1945–1946.
Goksugur N, Karabay O. Eyelash and eyebrow trichomegaly induced by interferon-alfa 2a. Clin Exp Dermatol 2007; 32: 583–584.
Karabay O, Goksugur N, Ogutlu A. Tongue hyperpigmentation during interferon therapy. Journal of Dermatology. 2011; 38: 290-291.
Johnson K, Sargent LA, Galizio C, Ubogu EU. Interferon- alfa-2b/ribavirin-induced vestibulocochlear toxicity with dysautonomia in a chronic hepatitis C patient. Eur J Gastroenterol Hepatol 2008; 20: 1110-1114.
Atuğ O, Akın H, Yılmaz Y, Sarı M, Tozun N. Pegylated interferon/ribavirin-induced sudden sensorineural hearing loss in a patient with chronic hepatitis C. J Gastrointestin Liver Dis 2009; 18: 256.
Elloumi H, Houissa F, Hadj BN, Gargouri D, Romani M, Kharrat J, Ghorbel A. Sudden hearing loss associated with peginterferon and ribavirin combination theraphy during hepatitis C treatment. World J gastroenterol 2007; 28: 5411-5412.
Formann E, Stauber R, Denk DM, Jessner W, Zollner G, Munda-Steindl P, Gangl A, Ferenci P. Sudden hearing loss in patients with chronic hepatitis C treated with pegylated interferon/ribavirin. Am J Gastroenterol 2004; 99: 873–877.
Wong VK, Cheong-Lee C, Ford JA, Yoshida EM. Acute sensorineural hearing loss associated with peginterferon and ribavirin combination theraphy during hepatitis C treatment: Outcome after resumption of theraphy. World J Gastroenterol 2005; 11: 5392-5393.
Piekarska A, Jozefowicz-Korczynska M, Wojcik K, Berkan E. Sudden hearing loss in chronic hepatitis C patient suffering from Turner syndrome, treated with pegylated interferon and ribavirin. Int J Audiol 2007; 46(7): 345-350.
Hagr A, Jamjoom D, Sanai F.M, Al Hamoudi W, Abdo A.A, Al-Arfaj A. Effect of interferon treatment on hearing of patients with chronic Hepatitis C. Saudi J Gastroenterol 2011; 2: 114-118.
Akyol MU, Sarac S, Akyol G, Atac A, Poyraz A, Belgin E, Turan E. Investigation of the ototoxic effects of interferon alpha2A on the mouse cochlea Otolaryngol Head Neck Surg 2001 ;124(1): 107-110.

There are 11 citations in total.

Details

Primary Language	Turkish
Journal Section	Letter to Editor
Authors	Oğuz Karabay This is me Mehmet Güven This is me Aziz Öğütlü This is me Süleyman Cesur This is me Deniz Gin This is me Nazan Tuna This is me
Publication Date	September 1, 2013
Published in Issue	Year 2013

Cite

APA	Karabay, O., Güven, M., Öğütlü, A., Cesur, S., et al. (2013). Pegile İnterferon alfa/ribavirin tedaviyle gelişen sensorinöral tipte işitme kaybı. Abant Medical Journal, 2(3), 248-249. https://doi.org/10.5505/abantmedj.2013.44153
AMA	Karabay O, Güven M, Öğütlü A, Cesur S, Gin D, Tuna N. Pegile İnterferon alfa/ribavirin tedaviyle gelişen sensorinöral tipte işitme kaybı. Abant Med J. September 2013;2(3):248-249. doi:10.5505/abantmedj.2013.44153
Chicago	Karabay, Oğuz, Mehmet Güven, Aziz Öğütlü, Süleyman Cesur, Deniz Gin, and Nazan Tuna. “Pegile İnterferon alfa/Ribavirin Tedaviyle gelişen sensorinöral Tipte işitme Kaybı”. Abant Medical Journal 2, no. 3 (September 2013): 248-49. https://doi.org/10.5505/abantmedj.2013.44153.
EndNote	Karabay O, Güven M, Öğütlü A, Cesur S, Gin D, Tuna N (September 1, 2013) Pegile İnterferon alfa/ribavirin tedaviyle gelişen sensorinöral tipte işitme kaybı. Abant Medical Journal 2 3 248–249.
IEEE	O. Karabay, M. Güven, A. Öğütlü, S. Cesur, D. Gin, and N. Tuna, “Pegile İnterferon alfa/ribavirin tedaviyle gelişen sensorinöral tipte işitme kaybı”, Abant Med J, vol. 2, no. 3, pp. 248–249, 2013, doi: 10.5505/abantmedj.2013.44153.
ISNAD	Karabay, Oğuz et al. “Pegile İnterferon alfa/Ribavirin Tedaviyle gelişen sensorinöral Tipte işitme Kaybı”. Abant Medical Journal 2/3 (September 2013), 248-249. https://doi.org/10.5505/abantmedj.2013.44153.
JAMA	Karabay O, Güven M, Öğütlü A, Cesur S, Gin D, Tuna N. Pegile İnterferon alfa/ribavirin tedaviyle gelişen sensorinöral tipte işitme kaybı. Abant Med J. 2013;2:248–249.
MLA	Karabay, Oğuz et al. “Pegile İnterferon alfa/Ribavirin Tedaviyle gelişen sensorinöral Tipte işitme Kaybı”. Abant Medical Journal, vol. 2, no. 3, 2013, pp. 248-9, doi:10.5505/abantmedj.2013.44153.
Vancouver	Karabay O, Güven M, Öğütlü A, Cesur S, Gin D, Tuna N. Pegile İnterferon alfa/ribavirin tedaviyle gelişen sensorinöral tipte işitme kaybı. Abant Med J. 2013;2(3):248-9.